Basso Capital Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Basso Capital Management’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8,704	Closed	-$1.87M	–	225
2020 Q3	$1.87M	Buy	+8,704	New	+$1.88M	0.65%	50
2020 Q2	–	Sell	-7,904	Closed	-$1.66M	–	208
2020 Q1	$1.66M	Buy	7,904 +7,440	+1,603%	+$1.56M	0.4%	78
2019 Q4	$97K	Sell	464 -789	-63%	-$165K	0.02%	169
2019 Q3	$259K	Sell	1,253 -9	-0.7%	-$1.85K	0.05%	151
2019 Q2	$264K	Sell	1,262 -1,253	-50%	-$255K	0.06%	139
2019 Q1	$507K	Hold	2,515	–	–	0.11%	116
2018 Q4	$495K	Buy	+2,515	New	+$493K	0.1%	104

Other funds holding RVPH

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Basso Capital Management's RVPH Position: Q4 2020 in Review

Basso Capital Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q4 2020, closing a stake of 8,704 shares — an estimated $1.87M sold.

Basso Capital Management first reported a position in RVPH in Q4 2018 and held it in 7 quarters. The position peaked at $1.87M in Q3 2020. 3 funds tracked by Wall St. Rank hold RVPH as of Q4 2020.

Basso Capital Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q4 2020 after selling out during the quarter.
Basso Capital Management sold 8,704 REVIVA PHARMA HLDGS INC shares in Q4 2020, an estimated $1.87M.
Basso Capital Management first reported a position in REVIVA PHARMA HLDGS INC in Q4 2018 and held it in 7 quarters.
Basso Capital Management's REVIVA PHARMA HLDGS INC position peaked at $1.87M in Q3 2020.
3 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q4 2020.

Based on Basso Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.